Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma

BACKGROUND: Liver cancer is the fifth most common cancer and the second cause of cancer-related deaths worldwide. Transarterial chemoembolization (TACE) is the best treatment of intermediate hepatocellular carcinoma (HCC). Doxorubicin is the most commonly used drug despite a low level of evidence. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Gaël Stéphane, Teyssier, Yann, Abousalihac, Mélodie, Seigneurin, Arnaud, Ghelfi, Julien, Sengel, Christian, Decaens, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969879/
https://www.ncbi.nlm.nih.gov/pubmed/31988592
http://dx.doi.org/10.3748/wjg.v26.i3.324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969879/
https://www.ncbi.nlm.nih.gov/pubmed/31988592
http://dx.doi.org/10.3748/wjg.v26.i3.324

Ejemplares similares